The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 406.00
Bid: 408.00
Ask: 409.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.245%)
Open: 408.00
High: 408.00
Low: 404.00
Prev. Close: 406.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stress Test Results

28 Jul 2023 17:35

RNS Number : 6282H
Banco Santander S.A.
28 July 2023
 

Banco Santander, S.A. ("Banco Santander"), in compliance with the Securities Market legislation, hereby reports the following:

OTHER RELEVANT INFORMATION

 

Banco Santander reports the results it has obtained in the most recent stress test exercise carried out by the European Banking Authority (EBA) and the European Central Bank (ECB).

The exercise covered a three-year period (end of 2022 - end of 2025) with two scenarios (baseline and adverse) applied to the consolidated perimeter of Santander Group. The CET1 ratio is a financial solvency ratio, the implementation of which is being carried out progressively by financial institutions pursuant to the transitional implementation schedules of the Capital Requirements Directive and Regulation and the International Financial Reporting Standard (IFRS) 9. During the phase-in period of these regulations, in addition to the CET1 Phased-in ratio (a capital ratio calculated pursuant to the transitional regime), which is the legally applicable ratio, the CET1 Fully Loaded ratio (a capital ratio calculated assuming a full implementation of the aforementioned regulations) is also used for information purposes.

The stress test exercise results in the following projected capital ratios for Santander Group for the periods and scenarios considered. A comparison of these projected ratios with the CET1 Fully Loaded ratio (12.04%) and the CET1 Phased-in ratio (12.18%) as of 31 December 2022 is also included in brackets:

 

ADVERSE SCENARIO

BASELINE SCENARIO

 

CET1 Fully Loaded

CET1 Phased- in

CET1 Fully Loaded

CET1 Phased- in

31/12/2023

10.53% (-1.50%)

10.96% (-1.22%)

13.39% (+1.35%)

13.39% (+1.21%)

31/12/2024

10.94% (-1.10%)

11.34% (-0.84%)

14.34% (+2.30%)

14.34% (+2.16%)

31/12/2025

10.33% (-1.70%)

10.33% (-1.84%)

14.44% (+2.40%)

14.44% (+2.26%)

 

Boadilla del Monte (Madrid), 28 July, 2023

 

 

IMPORTANT INFORMATION

Not a securities offer

This document and the information it contains does not constitute an offer to sell nor the solicitation of an offer to buy any securities.

Past performance does not indicate future outcomes

Statements about historical performance or growth rates must not be construed as suggesting that future performance, share price or results (including earnings per share) will necessarily be the same or higher than in a previous period. Nothing in this document should be taken as a profit and loss forecast.

Third Party Information

In this document, Santander relies on and refers to certain information and statistics obtained from publicly-available information and third-party sources, which it believes to be reliable. Neither Santander nor its directors, officers and employees have independently verified the accuracy or completeness of any such publicly-available and third-party information, make any representation or warranty as to the quality, fitness for a particular purpose, non-infringement, accuracy or completeness of such information or undertake any obligation to update such information after the date of this document. In no event shall Santander be liable for any use by any party of, for any decision made or action taken by any party in reliance upon, or for inaccuracies or errors in, or omission from, such publicly-available and third-party information contained herein. Any sources of publicly-available information and third-party information referred or contained herein retain all rights with respect to such information and use of such information herein shall not be deemed to grant a license to any third party.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKXPADFDEFA
Date   Source Headline
1st Apr 20225:57 pmRNSCapital reduction (2021 buy-back programme shares)
1st Apr 20224:30 pmRNS2022 AGM - Resolutions
1st Apr 20227:00 amRNSSantander confirms its financial targets for 2022
1st Apr 20227:00 amRNS2021 UK Annual Report
31st Mar 202211:33 amRNSBuyback programme: transactions 24 - 30 March
30th Mar 20223:21 pmRNSForm 8.3 - Clinigen Group Plc
30th Mar 20223:00 pmRNSForm 8.3 - Meggitt Plc
25th Mar 20222:29 pmRNSForm 8.3 - Meggitt plc
25th Mar 20222:27 pmRNSForm 8.3 - Clinigen Group plc
25th Mar 202212:51 pmRNSForm 8.3 - Ultra Electronics Holdings plc
24th Mar 202212:10 pmRNSBuyback programme: transactions 5 - 23 March
15th Mar 202212:40 pmRNSForm 8.3 - Meggitt plc
14th Mar 202211:51 amRNSCommencement of a program to repurchase own shares
9th Mar 202210:04 amRNSForm 8.3 - Meggitt Plc
3rd Mar 202211:58 amRNSForm 8.3 - Spectris plc
3rd Mar 202211:53 amRNSForm 8.3 - Oxford Instruments plc
1st Mar 20224:18 pmRNSOptional early redemption ISIN XS1602466424
28th Feb 202212:22 pmRNSDirector/PDMR Shareholding
28th Feb 20227:00 amRNSNotice of AGM
25th Feb 202211:33 amRNSForm 8.3 - Ultra Electronics Holdings plc
24th Feb 20225:35 pmRNSNotice of AGM
24th Feb 20222:49 pmRNSFurther re dividend declaration
24th Feb 20222:34 pmRNSDividend Declaration
18th Feb 202211:04 amRNSForm 8.3 - Meggitt plc
18th Feb 202210:55 amRNSForm 8.3 - Ultra Electronics Holdings plc
18th Feb 202210:47 amRNSForm 8.3 - Sanne Group plc
17th Feb 202210:54 amRNSForm 8.3 - Meggitt Plc
17th Feb 202210:49 amRNSForm 8.3 - Avast Plc
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSDirector/PDMR Shareholding
16th Feb 20223:20 pmRNSForm 8.3 - Meggitt Plc
16th Feb 20223:18 pmRNSForm 8.3 - Avast Plc
15th Feb 20229:07 amRNSForm 8.3 - Sanne Group plc
10th Feb 202211:37 amRNSForm 8.3 - Avast Plc
7th Feb 20224:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.